Icon

POSFREA (nda203050)- (EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML),EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML))

PALONOSETRON HYDROCHLORIDE AVYXA HOLDINGS
EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML),EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
No Yes
Expired Expired
None None
None No
Palonosetron Hydrochloride (HCl) Injection is a serotonin-3 (5-HT3) receptor antagonist indicated in adults for: • Moderately emetogenic cancer chemotherapy --prevention of acute and delayed nausea and vomiting associated with initial and repeat courses • Highly emetogenic cancer chemotherapy --prevention of acute nausea and vomiting associated with initial and repeat courses • Prevention of postoperative nausea and vomiting (PONV) for up to 24 hours following surgery.
0 0 0
Total Other Developers 5
Drugs with Suitability No
EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) ** ** - - -
EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.